期刊文献+

血管内皮细胞生长因子在结直肠组织中的表达及其意义 被引量:7

Expression of vascular endothelial growth factor in colorectal cancer and its clinical significance
原文传递
导出
摘要 目的 研究血管内皮细胞生长因子 (VEGF)和结直肠癌的关系。方法 应用流式细胞技术 (FCM)对结直肠癌肿瘤组织和癌旁正常粘膜组织标本进行VEGF的测定 ,结果用阳性细胞百分率和平均荧光强度表示。结合临床资料探讨VEGF和结直肠癌的生物学行为以及发生、发展与预后的关系。结果 VEGF在结直肠癌肿瘤组织中阳性细胞表达百分率为 5 7%± 2 9%、阳性细胞平均荧光强度为 2 4 %± 11% ,在癌旁正常粘膜组织标本中的阳性细胞表达百分率为 4 2 %± 2 4 %、阳性细胞平均荧光强度为 16 %± 7% ,两者比较差异具有显著意义 (P <0 0 5 ) ,且VEGF的阳性表达和结直肠癌Dukes分期相关 (P <0 0 1)。结论 血管内皮细胞生长因子 (VEGF)与结直肠癌的发生、发展和预后相关 ,但与结直肠癌生物学分化程度之间的关系还有待进一步验证。 Objective To evaluate the relationship between vascular endothelial growth factor (VEGF) and colorectal cancer. Methods Samples of cancer and adjacent normal mucosa were taken from 34 patients with colorectal cancer. The percentage and average fluorescence intensity pf VEGF positive cells in these samples were examined by using flow cytometry. Results The percentage of VEGF positive cells was 57%±29% in cancer tissue and 42%±24% in normal tissue ( P <0.05). The average fluorescence intensity of VEGF positive cells was 24%±11% in cancer tissue and 16%±7% in normal tissue ( P <0.01). The percentage of VEGF positive cells was 30%±22% in cancer of Dukes stage B and 72%±18% in cancer of Dukes stage C ( P <0.01). The average fluorescence intensity was 18%±25% in cancer of Dukes stage B and 27%±12% in cancer of Dukes stage C ( P <0.01). Conclusion VEGF is associated with the development and prognosis of colorectal cancer. Its relation with degree of differentiation of colorectal cancer remains to be studied.
出处 《中华医学杂志》 CAS CSCD 北大核心 2002年第7期481-483,共3页 National Medical Journal of China
关键词 血管内皮细胞生长因子 结直肠肿瘤 流式细胞技术 结肠癌 直肠癌 基因表达 Vascular endothelial growth factor Colorectal cancer Flow cycomety
  • 相关文献

参考文献2

二级参考文献15

  • 1李晓明.血管内皮细胞生长因子及其受体与肿瘤血管形成[J].国外医学(肿瘤学分册),1997,24(1):11-13. 被引量:54
  • 2Borgstrom P et al.Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Research . 1996
  • 3Kim KJ et al.Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature . 1993
  • 4Folkman J.Anti-angiogenesis: new concept for therapy of solid tumors. Annals of Surgery . 1972
  • 5Ferrara N et al.The biology of vascular endothelial growth factor. Endocrine Reviews . 1997
  • 6Brown LF,Berse B,Jackman RW,et al.Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human Pathology . 1995
  • 7Melnyk O et al.Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Research . 1996
  • 8Boom R,Sol CJA,Salimans MMM et al.Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology . 1990
  • 9Alvarez RD et al.A phage I study of recombinant aden- ??ovirus vector mediated delivery of an anti-erbB-2 singlechain(sFv) antibody gene for previously treated ovarian and extraovarian cancer patients. Human Gene Therapy . 1997
  • 10Menrad A et al.Novel antibodies directed against the extracellular domain of the human VEGF receptor type Ⅱ. Hybridoma . 1997

同被引文献45

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部